George J N, Woolf S H, Raskob G E
Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City 73190, USA.
Ann Med. 1998 Feb;30(1):38-44. doi: 10.3109/07853899808999383.
Idiopathic thrombocytopenic purpura (ITP, also known as immune thrombocytopenic purpura) affects both children and adults. In childhood, the peak age is 2-4 years, girls and boys are equally affected, and in most children, the disease is self-limited with spontaneous recovery occurring in several weeks to several months. In adults, ITP is most common among young women, and the disease is more insidious in its onset and chronic in its course. In both children and adults, there are important unresolved issues in diagnosis and management that have major cost implications. For this reason, the American Society of Hematology chose ITP as the disease topic for its initial practice guideline in 1993. In 1996, the practice guideline was published in Blood, the Journal of the American Society of Hematology. This review describes the principle features of ITP in children and adults, the process of development of the practice guideline for ITP, and the implications of the guideline for the diagnosis and management of patients with ITP.
特发性血小板减少性紫癜(ITP,也称为免疫性血小板减少性紫癜)可发生于儿童和成人。在儿童期,发病高峰年龄为2至4岁,男女发病率相同,且大多数儿童的疾病具有自限性,数周或数月内可自发恢复。在成人中,ITP在年轻女性中最为常见,疾病起病较为隐匿,病程呈慢性。在儿童和成人中,诊断和管理方面都存在重要的未解决问题,这具有重大的成本影响。因此,美国血液学会在1993年选择ITP作为其首个实践指南的疾病主题。1996年,该实践指南发表在《美国血液学会杂志》《血液》上。本综述描述了儿童和成人ITP的主要特征、ITP实践指南的制定过程以及该指南对ITP患者诊断和管理的影响。